Mass Tort Marketing: A 2026 Guide for Plaintiff Law Firms
What mass tort marketing is, how the funnel actually works, what campaigns cost, where the compliance exposure sits, and how to evaluate a mass tort marketing agency before you sign.
The short version
Mass tort marketing is the practice of identifying and acquiring individual claimants for litigation where many people were harmed by the same product, drug, device, or conduct. It differs from general legal marketing in three ways: campaigns are time-boxed to the life of a specific litigation, respondents must be screened against medical and exposure criteria before they count as leads, and performance is measured on cost per signed retainer rather than on cost per lead or brand awareness.
What is mass tort marketing?
Mass tort marketing is claimant acquisition for litigation where a large number of people were harmed by the same cause. The work is closer to direct-response performance marketing than to traditional law firm branding: a campaign has a defined injury profile to find, a screening standard to apply, a compliance record to produce, and a signed retainer to deliver.
That framing matters because it changes what “working” means. A general legal marketing program can be judged on impressions, rankings, and inbound calls. A mass tort campaign that produces thousands of inbound calls and no signed cases has failed, regardless of how the top-line numbers look.
What is the difference between mass tort marketing and personal injury marketing?
Personal injury marketing targets a geography and waits for incidents to happen inside it; mass tort marketing targets an injury profile that already exists across the country. A car accident firm cannot make more collisions occur, so it competes for local search intent at the moment of need. A mass tort campaign, by contrast, is chasing a population that has already been harmed but frequently does not yet know the harm is actionable — which means the campaign has to create the connection between a medical event and a legal claim, not just capture existing demand.
Three practical consequences follow. Mass tort creative has to do more educational work. Screening is far heavier, because eligibility turns on medical and exposure facts rather than on whether an accident occurred. And campaigns have a shelf life tied to the litigation itself — statute of limitations deadlines, MDL filing postures, and settlement programs all close windows that no amount of budget can reopen.
What qualifies as a mass tort?
A mass tort is a civil action in which numerous plaintiffs bring claims against one or a few defendants arising from the same or similar harm. The defining feature — and the thing that separates it from a class action — is that each plaintiff’s case remains individual. Damages are assessed person by person, and a claimant can succeed while another fails on the same theory.
Cases are frequently consolidated into a multidistrict litigation, or MDL, which centralizes pretrial proceedings before a single federal judge for efficiency. Consolidation is procedural only: the cases do not merge, and after common discovery and bellwether trials, unresolved cases can be remanded to their originating courts.
What are the four major kinds of mass torts?
Mass torts are conventionally grouped into four categories, and the category largely determines how a campaign is built.
- 1. Pharmaceutical torts
- Claims arising from prescription and over-the-counter drugs. Claimants are identifiable through prescription history and diagnosis, which makes targeting relatively precise. Examples on our roster include Depo-Provera, Ozempic and GLP-1, and Tylenol acetaminophen.
- 2. Medical device torts
- Claims involving implants, surgical hardware, and equipment. Device identification is the central screening challenge, since claimants often cannot name the product implanted in them. See Bard PowerPort, hernia mesh, and Philips CPAP.
- 3. Toxic and environmental torts
- Claims from occupational or environmental exposure to a harmful substance. Latency periods are long and exposure is often occupational, so campaigns target job history and geography as much as diagnosis. See Roundup, AFFF firefighting foam, silicosis, and Camp Lejeune.
- 4. Consumer product and mass disaster torts
- Claims from a widely sold defective product or a single catastrophic event. Where a disaster is geographically bounded, campaign targeting is unusually efficient. See talcum powder and wildfire litigation.
The full roster of active litigations we run campaigns for is indexed on the mass tort leads page.
The mass tort marketing funnel: awareness to signed retainer
Every mass tort campaign moves a person through the same five stages. Most underperforming programs are not losing on media cost — they are losing between stages three and four, where screened claimants go cold waiting for someone to call them back.
Reach the injured population
Identify where the claimant population actually is by exposure profile and demographics, then buy media against it — paid social for younger pharmaceutical torts, streaming and broadcast for older-skewing exposure torts, search for litigations with public awareness.
Convert response to a screened claimant
Route responses into a screening flow that tests the litigation's real case criteria — exposure window, diagnosis, product identification, and state eligibility — before anyone is treated as a lead.
Capture compliant consent
Record TCPA consent at the point of submission with a certified consent record from TrustedForm or Jornaya, preserving the disclosure language and the session evidence alongside the contact data.
Deliver to intake without delay
Transfer qualified claimants to the firm's intake team in real time. Speed to first contact is the single largest controllable variable in retainer conversion.
Sign the retainer and measure CPSR
Track every campaign to signed retainers rather than to leads, and recompute cost per signed retainer by tort and by channel weekly so budget moves to what is actually signing cases.
Stages three and four are covered in operational detail on our mass tort intake page.
How do law firms get clients for mass tort cases?
Through four routes, usually in combination: direct-to-claimant advertising, purchased leads or signed cases from acquisition vendors, co-counsel and referral relationships, and organic channels including search engine optimization, content, and earned media. Firms that rely on a single route tend to discover its ceiling at the worst possible moment — when a litigation breaks and everyone is bidding for the same inventory at once.
Digital marketing channels
Paid search captures claimants who already suspect a connection between their injury and a product. Paid social — Meta, TikTok — reaches the much larger group who do not, using demographic and interest signals that proxy for exposure profile. Programmatic display and OTT extend reach for torts where search intent is thin. Each has a different cost curve and a different creative discipline.
Traditional media channels
Broadcast and cable television, radio, and direct response print remain effective for older-skewing exposure torts, where the claimant population indexes low on social platforms. Traditional media is also where mass tort advertising has the longest track record, and where creative and frequency discipline matter more than targeting sophistication.
What is the role of SEO in mass tort marketing?
Mass tort search engine optimization captures claimants during the research phase — the weeks or months between noticing a symptom and contacting a lawyer — and it captures firms researching vendors. Because it compounds slowly, SEO cannot be switched on when a litigation breaks; it is infrastructure built ahead of need. Its highest return is on torts with long research cycles and for firms that intend to be present across multiple litigations over several years rather than to run one campaign and stop.
In 2026 that also means answer engine visibility. A growing share of claimant and law firm research now resolves inside AI Overviews and assistant responses rather than on a results page, and being the cited source in those answers is a distinct discipline from ranking first in the blue links.
A full channel-by-channel breakdown — where each platform works, where it fails, and which torts it fits — is in our mass tort advertising landscape guide.
What should a mass tort campaign cost?
Cost per lead is the wrong unit of account, and it is the single most common reason firms misjudge a vendor. A $40 lead that signs at 2% costs $2,000 per retainer. A $180 lead that signs at 22% costs about $818. The cheaper lead is more than twice as expensive.
The operative metric is cost per signed retainer. It varies by tort according to three things: how prevalent the claimant population is, how much competition is bidding on the same media, and how restrictive the case criteria are. Tight criteria raise CPSR and simultaneously raise case quality — which is the trade-off worth having an explicit conversation about before a campaign launches, not after.
What are mass tort leads, and what makes a good one?
A mass tort lead is a person who has responded to a campaign, been screened against the litigation’s case criteria, and consented to contact. The word covers an enormous quality range. Four attributes separate a lead that signs from one that wastes intake capacity:
- Exclusivity. Delivered to one firm, never resold or syndicated to competitors chasing the same claimant.
- Real screening. Tested against exposure window, diagnosis, product identification, and state eligibility — not just a name and a phone number.
- Documented consent. A certified TCPA consent record preserving the disclosure language shown at submission.
- Freshness. Delivered within minutes. Retainer conversion decays sharply with time to first contact.
Our per-tort pricing model is set out on the mass tort lead generation page.
Lead generation ethics and compliance
Mass tort marketing sits on top of three separate regulatory surfaces, and a failure on any one of them can cost far more than a campaign earns.
TCPA and consent
Contacting a claimant without valid prior express written consent carries statutory damages per call or text. Certified consent capture and retention of the disclosure shown at submission are the baseline defense. Consent rules have moved repeatedly in recent years — confirm current requirements with counsel rather than relying on a vendor’s assurance.
Attorney advertising rules
State bar rules govern solicitation, required disclaimers, claims about results, and fee sharing with non-lawyers. They vary by jurisdiction, and responsibility for a vendor’s creative sits with the firm whose name is on it.
Truthful claim substantiation
Creative that implies a settlement exists where none does, or suggests a guaranteed payment amount, invites both regulatory attention and claimant attrition when the promise meets reality at intake.
How to choose a mass tort marketing agency
Most mass tort marketing companies will show you testimonials and aggregate volume. Neither predicts what your cost per signed retainer will be. Five questions do, and any agency worth hiring will answer all five in writing.
- Are leads exclusive to my firm, or shared? If shared, with how many other firms?
- Do you quote on cost per signed retainer or cost per lead — and will you show historical CPSR for this specific tort?
- Who owns the consent records, contact data, and call recordings if we stop working together?
- What exactly does your screening test, and can I see the script?
- What is your average time from claimant submission to delivery into our intake?
We compare the major providers, including ourselves, in the top mass tort marketing firms guide.
Get a per-tort cost per signed retainer figure
Bring the torts you are considering and your current intake conversion rate. In 30 minutes we will give you a realistic CPSR range for each, the volume your docket can absorb, and a straight answer on which of them are not worth entering right now.
Mass tort marketing: frequently asked questions
- What is mass tort marketing?
- Mass tort marketing is the practice of identifying and acquiring individual claimants for litigation where many people were harmed by the same product, drug, device, or conduct. Unlike general legal marketing, which builds a firm's brand across all practice areas, mass tort marketing runs time-boxed campaigns against a specific injury profile, screens respondents against medical and exposure criteria, and is measured on signed retainers rather than on inquiries.
- What qualifies as a mass tort?
- A mass tort is a civil action where numerous plaintiffs bring claims against one or a few defendants over the same or similar harm. Unlike a class action, each plaintiff's case remains individual — with its own facts, damages, and outcome — even when cases are consolidated into a multidistrict litigation (MDL) for pretrial proceedings.
- What are the four major kinds of mass torts?
- Mass torts are generally grouped into four categories: pharmaceutical torts involving prescription and over-the-counter drugs; medical device torts involving implants and equipment; toxic torts involving environmental or occupational exposure to harmful substances; and mass disaster or consumer product torts arising from a single catastrophic event or a widely sold defective product.
- What are mass tort leads?
- A mass tort lead is a person who has responded to a campaign, been screened against the litigation's case criteria, and consented to contact by a law firm. Quality varies enormously: an unscreened form fill and a fully qualified claimant with documented exposure, a confirmed diagnosis, and a certified consent record are both sold as 'leads' but differ by an order of magnitude in retainer conversion.
- How much should a law firm pay for mass tort lead generation?
- Cost per lead is the wrong unit. The number that governs profitability is cost per signed retainer (CPSR), which varies by tort from the low hundreds to several thousand dollars depending on claimant prevalence, media competition, and how restrictive the case criteria are. A firm should compare CPSR against expected case value and its own intake conversion rate before committing to any spend level.
- What is the role of SEO in mass tort marketing?
- Mass tort SEO captures claimants during the research phase, before they are ready to speak to a lawyer, and it captures law firms researching vendors. It is slower than paid media and cannot be switched on when a litigation breaks, so it functions as compounding infrastructure rather than a launch channel — most valuable for torts with long research cycles and for firms building durable presence across multiple litigations.
- How do law firms get clients for mass tort cases?
- Through four routes: direct-to-claimant advertising across paid social, search, streaming, and traditional media; purchased leads or signed cases from acquisition vendors; co-counsel and referral relationships with other firms; and organic channels including SEO, content, and earned media. Most firms running significant mass tort volume use a combination rather than relying on any single route.
- How long does it take to settle a mass tort case?
- Mass tort litigation typically runs for years rather than months. Cases consolidated into an MDL move through common discovery and bellwether trials before any global resolution becomes likely, and that sequence commonly takes three to seven years from consolidation. Individual claimants within a resolved settlement program may then wait further months for administration and disbursement.
- How much do mass tort attorneys make?
- Mass tort work is handled on contingency, with fees commonly in the 33% to 40% range of recovery, subject to state rules and to any common benefit assessment the court orders for MDL leadership. Firm economics depend less on the fee percentage than on acquisition cost, case volume, and how long capital is tied up before resolution — which is why cost per signed retainer, not fee rate, is the operative metric.
- What should I look for in a mass tort marketing agency?
- Ask whether leads are exclusive or shared, whether pricing is quoted on cost per signed retainer or cost per lead, who owns the consent records and call recordings, what the screening criteria actually are, and whether the agency will show per-tort historical CPSR rather than aggregate testimonials. An agency unwilling to answer those five questions in writing is quoting on volume, not on outcomes.
This guide is written for law firms evaluating claimant acquisition programs. It is general information about marketing practice, not legal advice, and it does not address the bar rules of any particular jurisdiction.